United Therapeutics (UTHR) Change in Inventory (2009 - 2026)

United Therapeutics has disclosed Change in Inventory across 18 years of filings, most recently posting $40.1 million for Q1 2026.

• Change in Inventory for Q1 2026 came in at $40.1 million, up 258.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $81.5 million (up 67.01% YoY), and the FY2025 annual result was $52.6 million, up 12.15% from the prior year.
• Change in Inventory came in at $40.1 million for Q1 2026 at United Therapeutics, up from $16.5 million in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $40.1 million in Q1 2026 to a low of -$5.7 million in Q1 2022.
• The 5-year median for Change in Inventory is $9.3 million (2024), against an average of $9.8 million.
• Peak annual rise in Change in Inventory reached 13800.0% in 2022, while the deepest fall reached 359.09% in 2022.
• United Therapeutics' Change in Inventory stood at $13.9 million in 2022, then sank by 49.64% to $7.0 million in 2023, then surged by 65.71% to $11.6 million in 2024, then jumped by 42.24% to $16.5 million in 2025, then surged by 143.03% to $40.1 million in 2026.
• The last three Change in Inventory figures came in at $40.1 million (Q1 2026), $16.5 million (Q4 2025), and $17.5 million (Q3 2025), per Business Quant data.